Riskpilot← Back to searchSign inGet full accessNouri Medical AB
ABActiveOrg 5592729031Gränsgatan 22 CGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2025
SEK 15K
-73% vs 2024
EBITDA margin
15.5%
-93% vs 2024
Equity ratio
88.5%
Financial strength
Net profit 2025
SEK 7K
-87% vs 2024
| Revenue | SEK 15K | -73% |
| EBITDA | SEK 2K | -93% |
| Net profit | SEK 7K | -87% |
| Total assets | SEK 271K | +5% |
| Equity | SEK 240K | +3% |
| Employees | 0 | — |
Legal name
Nouri Medical AB
Org number
5592729031
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarbemanning, konsultationer inom medicin, utbildning inom hälso- och sjukvård samt därmed förenlig verksamhet. Medicinska och estetiska injektionsbehandlingar. Läkaruppdrag för öppenvården. Vidare ska bolaget äga och förvalta aktier, fast och lös egendom samt därmed förenlig verksamhet.
Address
Gränsgatan 22 C
Email
ahmednouri@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 434 | 209 | 156 | 54 | 15 |
| Staff expenses | — | — | — | — | −1 |
| EBITDA | 389 | 114 | 107 | 31 | 2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 389 | 114 | 107 | 31 | 2 |
| Net financials | −3 | 1 | — | 6 | 7 |
| Profit before tax | 289 | 115 | 166 | 74 | 9 |
| Tax | −62 | −24 | −35 | −16 | −2 |
| Net profit | 227 | 91 | 131 | 58 | 7 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 434 | 546 | 582 | 259 | 271 |
| Equity | 252 | 343 | 474 | 232 | 240 |
| Long-term debt | 3 | 0 | 0 | 0 | 0 |
| Short-term debt | 82 | 106 | 71 | 27 | 31 |
| Total debt | 85 | 106 | 71 | 27 | 31 |
EBITDA margin
15.5%
This company
15.8%
Market median
+2% vs market
20212025
Equity ratio
88.5%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
3.0%
This company
18.4%
Market median
-84% vs market
20212025
Net profit margin
50.0%
This company
8.1%
Market median
+517% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nouri Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ahmed Riad Nouri | Chief Executive Officer | 0 companies |
| Shabaad Sabri Jabbar | Deputy Board Member | 0 companies |
| Shabaad Sabri Jabbar | Deputy Board Member | 0 companies |